Patient Guide: A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 209 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06830720
Status: 🟢 Enrolling Now
Condition: Breast Neoplasms
Phase: Not Specified

Where You Can Participate

This study is available at 209 locations across the country.

Top locations include:
  • • Filderstadt, Baden-Wurttemberg
  • • Freudenstadt, Baden-Wurttemberg
  • • Heidenheim, Baden-Wurttemberg
  • • And 206 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence - Join Clinical Trial NCTNCT06830720

How to Join This Clinical Trial - NCTNCT06830720

Learn how to participate in this Not Specified trial studying an investigational therapy for Breast Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Breast Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Breast Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06830720 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 209 locations. Find a study site near you:

Clinical Research Site

Filderstadt, Baden-Wurttemberg 70794 - Germany

Status: RECRUITING

Clinical Research Site

Freudenstadt, Baden-Wurttemberg 72250 - Germany

Status: RECRUITING

Clinical Research Site

Heidenheim, Baden-Wurttemberg 89522 - Germany

Status: RECRUITING

Clinical Research Site

Konstanz, Baden-Wurttemberg 78464 - Germany

Status: RECRUITING

Clinical Research Site

Mannheim, Baden-Wurttemberg 68161 - Germany

Status: RECRUITING

Clinical Research Site

Mannheim, Baden-Wurttemberg 68165 - Germany

Status: RECRUITING

Clinical Research Site

Nürtingen, Baden-Wurttemberg 72622 - Germany

Status: RECRUITING

Clinical Research Site

Pforzheim, Baden-Wurttemberg 75179 - Germany

Status: RECRUITING

Clinical Research Site

Ravensburg, Baden-Wurttemberg 88212 - Germany

Status: RECRUITING

Clinical Research Site

Reutlingen, Baden-Wurttemberg 72764 - Germany

Status: RECRUITING

And 199 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Breast Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships